Isoastragaloside I suppresses LPS-induced tight junction disruption and monocyte adhesion on bEnd.3 cellsviaan activating Nrf2 antioxidant defense system
Open Access
- 2 January 2018
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 8 (1) , 464-471
Abstract
Disruption of the blood-brain-barrier (BBB), a crucial event for the entry of inflammatory cells into brain, is a prerequisite for the pathogenesis of many cerebral diseases. Oxidative stress is one of the well-known factors that accounts for the leakage of the BBB, which can be alleviated by the activation of the nuclear factor erythroid 2-related factor 2 (Nrf2) signaling pathway. Isoastragaloside I (ISOI) is a cycloartane glycoside isolated from Radix Astragali, a clinical widely used traditional Chinese medicine. In the present study, the effect of ISOI on LPS-induced bEnd.3 cells was assessed and the underlying molecular mechanisms were investigated. Our results showed that ISOI pre-treatment inhibited the reduction of TEER, prevented the increase of NaF extravasation and ROS production, and rescued the down-regulated tight-junction (TJ) protein level in bEnd.3 cells stimulated with LPS. Meanwhile, it significantly activated Nrf2 activity, increased its nuclear translocation, thereby, enhanced the expression of its downstream molecules such as NQO1 and HO-1. When Nrf2 was silenced by siRNA, ISOI could not rescue the decrease of TJ proteins induced by LPS any more. In addition, ISOI pre-treatment reduced the elevation of VCAM-1, IL-1β and TNF-α at either protein or mRNA levels, and abrogated the increased adhesion of the monocyte JAWS II cells onto bEnd.3 cells stimulated with LPS. Taken together, these results indicated that ISOI could protect the integrity of the BBB under inflammatory conditions, which was probably mediated through activating the Nrf2 antioxidant pathway.Keywords
Funding Information
- National Natural Science Foundation of China (81673626, 81603354)
This publication has 41 references indexed in Scilit:
- Astragaloside IV Attenuates Experimental Autoimmune Encephalomyelitis of Mice by Counteracting Oxidative Stress at Multiple LevelsPLOS ONE, 2013
- Establishment of a simplified in vitro porcine blood–brain barrier model with high transendothelial electrical resistanceBrain Research, 2013
- Blood–Brain Barrier Permeability and Long-Term Clinical and Imaging Outcomes in Cerebral Small Vessel DiseaseStroke, 2013
- Tight junctions at the blood brain barrier: physiological architecture and disease-associated dysregulationFluids and Barriers of the CNS, 2012
- Cyanidin-3-O-glucoside Protection against TNF-α-Induced Endothelial Dysfunction: Involvement of Nuclear Factor-κB SignalingJournal of Agricultural and Food Chemistry, 2010
- Selective Elevation of Adiponectin Production by the Natural Compounds Derived from a Medicinal Herb Alleviates Insulin Resistance and Glucose Intolerance in Obese MiceEndocrinology, 2009
- The Blood-Brain Barrier in Health and Chronic Neurodegenerative DisordersNeuron, 2008
- Enhancing Expression of Nrf2-Driven Genes Protects the Blood–Brain Barrier after Brain InjuryJournal of Neuroscience, 2007
- Pericytes from Brain Microvessels Strengthen the Barrier Integrity in Primary Cultures of Rat Brain Endothelial CellsCellular and Molecular Neurobiology, 2007
- 3-Hydroxyanthranilic acid, one of l-tryptophan metabolites, inhibits monocyte chemoattractant protein-1 secretion and vascular cell adhesion molecule-1 expression via heme oxygenase-1 induction in human umbilical vein endothelial cellsAtherosclerosis, 2006